You just read:

Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Myotonic Dystrophy

News provided by

Audentes Therapeutics, Inc.

Apr 08, 2019, 07:00 ET